Robert M. Di Scipio, President and CEO
Mr. Di Scipio has 25 years experience in business development, sales management, corporate law, and finance including executive positions with biotechnology, software and technology companies. Prior to joining Aegis, Mr. Di Scipio served as Vice President, Business Development and Associate General Counsel, and was a member of the Executive Committee, at Martek Biosciences Corporation (MATK:NASDAQ). He was Vice President, Corporate Development and General Counsel and Secretary for OmegaTech, where as a member of the Executive Committee, he managed legal affairs, Asia/Pacific sales, the Gold Circle Farms consumer brand, intellectual property strategy and licensing, and negotiated the company's sale to Martek. Earlier in his career, Mr. Di Scipio was in the private practice of law and worked as a tax attorney with Coopers & Lybrand. He currently sits on the Board of Directors of ePals, Inc. (which licenses its safe email technology and digital literacy curriculum to the K-12 education market), and the Board of the Deming Center for Entrepreneurship at the University of Colorado Leeds School of Business. Mr. Di Scipio is also the founder of Skyland Capital LLC, a venture capital firm. He received his B.A. from the University of Michigan and a J.D. from Pace University. He is a member of the bars of New York and Connecticut.
Justin O. Neway, Ph.D., Founder, Vice President and Chief Science Officer
Mr. Neway has 25 years experience in pharmaceutical and biotechnology process development and manufacturing, and in the application of software solutions to quality compliance and operational issues in pharmaceutical and biotherapeutic manufacturing. During the 15 years prior to founding Aegis in 1996, Dr. Neway was with Wyeth Biosciences, Chiron Corporation and Baxter Hemoglobin Therapeutics, where he held increasingly responsible positions including Technical Manager, Principal Scientist, Project Leader for the CMC section of the IL-2 BLA, Department Director, and Director of Process Sciences. During this time, Dr. Neway became intimately familiar with the practical difficulties of accessing process development and manufacturing data from separate databases and on paper records, and the significant paybacks achievable from connecting to that data in real time for investigational analysis. Dr. Neway received his B.Sc. (Microbiology, 1975) and M.Sc. (Biochemistry, 1977) from the University of Calgary ( Canada ) and his Ph.D. in Biochemistry from the University of Illinois ( USA ) in 1982. He has published refereed papers in scientific journals as well as other papers, editorials, op-ed pieces and interviews in trade publications. He has also presented technical papers and chaired technical conferences in the field of pharmaceutical manufacturing, quality compliance and data analysis. Justin's LinkedIn Profile
Geri L. Studebaker, Vice President, Customer Operations
Ms. Studebaker has over 14 years of experience in software marketing and applications. Prior to joining Aegis, Ms. Studebaker was Sr. Director of Worldwide Marketing for Webb Interactive, an e-business software provider for the small to medium-size business. Prior to Webb, Ms. Studebaker held several positions within JD Edwards, the most recent being Sr. Marketing Manager. As project lead for Knowledge Management, Ms. Studebaker developed and managed the entire product lifecycle, from initial product concept and proposal through development efforts, product positioning and global rollout. Ms. Studebaker holds a BS in Corporate Finance from the University of California, San Diego , and an MBA and MS in Marketing from the University of Colorado.
Mark Isaacs, Vice President, Sales
Mr. Isaacs has twenty years experience of senior level, global business development and sales management focused on bringing innovative solutions to the life sciences industry. He has an in-depth understanding of the drug development process and the challenges in scaling up manufacturing and improving product quality and process robustness. Mr. Isaacs previously led Conformia's sales operations specializing in enterprise software. Prior to this Mr Isaacs served on the Executive Board of Hyprotech - a process modeling enterprise software company - and contributed to its tripling in size within five years before the company was acquired by Aspentech in 2002. Mr. Isaacs also led a team responsible for commercializing the Batch Design Kit - software focused on improving process development and manufacturing supported by world-class consultants expert in critical pharmaceutical unit operations such as crystallization, filtration and drying used by companies such Pfizer, Bristol-Myers Squibb, Abbott Laboratories, Merck, GlaxoSmithKline and Astra Zeneca. Mr. Isaacs holds a First Class Masters Degree in Natural Sciences and Chemical Engineering from St John's College, Cambridge University in the UK, is a member of the International Society for Pharmaceutical Engineering and has served on various Industry Advisory Boards including the Advisory Committee of Management Division for the American Institute of Chemical Engineers.
Mike Neal, Chief Technology Officer
Mr. Neal has over 25 years experience in software development. In his early career, he worked on leading edge technologies in user experience design and visualization. He progressed from software engineer to project manager to executive. He has served as a Chief Technology Officer for companies ranging from early stage to large publicly traded companies and has run global software development organizations with offices in 10 countries. Mr. Neal has nineteen awarded patents in search, database, ontology, and data management technologies. His technical career has been marked by a string of commercially successful software products delivered on or ahead of schedule and on or under budget. He has particular expertise in the field of software engineering, software usability, and product management. Mr. Neal earned a Bachelor of Science in Computer Science from the University of South Carolina and a Master of Arts in Media Psychology from Fielding Graduate University. He is a Senior Member of the Association for Computing Machinery (ACM), the ACM Special Interest Group Computer Human Interface (SIGCHI), and IEEE.
Stephanie Brock, Controller
For over 15 years, Ms. Brock has been involved as a senior finance manager for a variety of companies. She most recently worked as Director of Finance & Administration for HiveLive, Inc., where she was responsible for the planning and management of day-to-day finance and administrative operations. Previously, Ms. Brock worked at NextAction, Inc., as the Director of Accounting and Assistant Secretary of the Corporation. During her tenure at NextAction, she was instrumental in establishing the start-up company's organizational infrastructure. At Orchard Construction, Inc., Ms. Brock was the Chief Financial Officer. With Abacus Direct, Inc. she was Assistant Controller where she managed all accounting functions for the public corporation with a $500mm market capitalization.